Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Efficacy and safety of LixiLan, a titratable fixed-ratio combination of Lixisenatide and insulin glargine, versus insulin glargine in type 2 diabetes inadequately controlled on metformin monotherapy: the LixiLan proof-of-concept randomized trial
Koliwad addressed the seeming contradiction between the drug's known side effects, including muscle mass and bone density loss, and its potential anti-aging effects
Dinner should aim for 40 to 50 grams of protein minimum
Dizziness, trouble walking normally, anxiety, nervousness, weakness, as well as uncoordinated movements are some of these side effects
US$ 29.51
US$ 25.87
US$ 28.11
US$ 22.22
